Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.50 |
| ▸ | HMGCR | P04035 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | GGT1 | P19440 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | ARG1 | P05089 | 1/20 | 0.43 |
| ▸ | ARG2 | P78540 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | CPT2 | P23786 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL162455 | 1.00 | TSHR (0.55) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| SCHEMBL1875520 | 1.00 | TSHR (0.55) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| Hydrochloric Acid SCHEMBL28641269 | 0.97 | CYP2C19 (0.52) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| SCHEMBL2721718 | 0.85 | CYP2C19 (0.41) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| Water SCHEMBL18669981 | 0.82 | TSHR (0.39) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| Phenol SCHEMBL28180129 | 0.82 | BLM (0.56) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| SCHEMBL161723 | 0.81 | GGT1 (0.46) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| SCHEMBL161722 | 0.81 | GGT1 (0.46) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| SCHEMBL573396 | 0.81 | GGT1 (0.46) | TSHRCYP2C19HIF1ACYP2D6ADRA1A | |
| SCHEMBL1986433 | 0.81 | GGT1 (0.46) | TSHRCYP2C19HIF1ACYP2D6ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117285626-A | Alpha v beta 6 integrin ligand and its application | 箭头药业股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116670151-A | Antibacterial cyclic peptides targeting acinetobacter and other gram negative pathogens | 犹他大学研究基金会 | 2023-08-29 | — | — | CN | claimed |
| EP-3288599-B1 | WOUND PACKING MATERIAL COMPRISING CHEMOEFFECTOR | CHEMOKIND INC (US) | 2023-06-07 | — | — | EP | claimed |
| US-20230105982-A1 | INSULIN-INCRETIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2023-04-06 | — | — | US | claimed |
| US-20220380425-A1 | ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE | CADILA HEALTHCARE LIMITED (IN) | 2022-12-01 | — | — | US | claimed |
| EP-3993820-A1 | ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 | Cadila Healthcare Limited (IN) | 2022-05-11 | — | — | EP | claimed |
| WO-2021001804-A1 | ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE | CADILA HEALTHCARE LIMITED (IN) | 2021-01-07 | — | — | WO | claimed |
| US-20200399311-A1 | NOVEL PEPTIDE BASED PCSK9 VACCINE | ZYDUS LIFESCIENCES LIMITED (IN) | 2020-12-24 | — | — | US | claimed |
| EP-3609532-A1 | NOVEL PEPTIDE BASED PCSK9 VACCINE | Cadila Healthcare Limited (IN) | 2020-02-19 | — | — | EP | claimed |
| CN-110536696-A | PCSK9 vaccine based on new peptide | CADILA HEALTHCARE LTD | 2019-12-03 | — | — | CN | claimed |
| WO-2017160669-A1 | INSULIN-INCRETIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2017-09-21 | — | — | WO | claimed |
| US-20160318987-A1 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2016-11-03 | — | — | US | claimed |
| EP-3080153-A2 | PROTEASE RESISTANT PEPTIDES | Medimmune Limited (GB) | 2016-10-19 | — | — | EP | claimed |
| WO-2015086686-A2 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2015-06-18 | — | — | WO | claimed |
| EP-2644185-A1 | THICK CLEANING COMPOSITION | Suzhou Yuansuji Chemical Industry Co., Ltd. (CN) | 2013-10-02 | — | — | EP | claimed |
| CN-103338743-A | Thick cleaning composition | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD | 2013-10-02 | — | — | CN | claimed |
| US-20130251648-A1 | THICK CLEANING COMPOSITION | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO., LTD. (CN) | 2013-09-26 | — | — | US | claimed |
| US-20120264685-A1 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP 1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | CADILA HEALTHCARE LIMITED (IN) | 2012-10-18 | — | — | US | claimed |
| EP-2491054-A2 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | Cadila Healthcare Limited (IN) | 2012-08-29 | — | — | EP | claimed |
| WO-2011048614-A2 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | CADILA HEALTHCARE LIMITED (IN) | 2011-04-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230105982-A1 | INSULIN-INCRETIN CONJUGATES | GIPR, GLP1R, GCGR | TSHR 116/4885CYP2C19 4050/4885HIF1A 3920/4885 |
| US-20220380425-A1 | ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE | HDGFL3, PCSK9, TEK | TSHR 3468/4885CYP2C19 4723/4885HIF1A 1898/4885 |
| US-20120264685-A1 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP 1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | GIPR, GLP1R, DPP4 | TSHR 208/4885CYP2C19 199/4885HIF1A 3259/4885 |
| US-20200399311-A1 | NOVEL PEPTIDE BASED PCSK9 VACCINE | PCSK9, PCSK7, PCSK6 | TSHR 2512/4885CYP2C19 3030/4885HIF1A 4577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.